PROT# MEL-041509: Phase II Randomized, Double-Blind, Placebo-Controlled, Three-Arm,Dose-Finding, Study to Evaluate the Safety and Efficacy of Erlotinib in the Treatment of Moderate to Severe Psoriasis
- West, Dennis P (Co-PD/PI)
- Singri, Prashant (Co-PD/PI)
- Laumann, Anne E (PD/PI)
Project: Research project